The deubiquitinating enzyme Usp9X was shown to be overexpressed in various human cancers, including glioblastoma (Supplementary Figure S1), which supports the notion that deubiquitinating enzymes represent a valid target in this disease and that their inhibition may add to a concerted strategy against glioblastoma [4]. The gene discussed is USP9X; the disease is glioblastoma.